Advertisement

Dose Rate and Therapeutic Gain

  • R. G. Fairchild
Part of the Basic Life Sciences book series (BLSC, volume 50)

Abstract

There is a consensus that previous difficulties encountered in U.S. clinical trials of NCT resulted from the use of inorganic compounds showing no tumor selectivity, and the use of thermal neutron beams which are known to have poor penetration in tissue (HVL ≈ 1.8 cm). Consequently, normal surface tissues were over-exposed, while viable tumor remained at depth. Since then, these problems have been largely circumvented through the development of epithermal neutron beams with better tissue penetration, and the synthesis of various boronated biomolecules which demonstrate tumor selectivity.

Keywords

Neutron Beam Boron Neutron Capture Therapy Therapeutic Gain Effective Dose Rate Boron Hydride 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    T. Kobayashi and K. Kanda, Analytical calculation of boron -10 dosage in cell nucleus for neutron capture therapy, Radiat. Res. 91: 77 (1982).PubMedCrossRefGoogle Scholar
  2. 2.
    D. Gabel, S. Foster, and R. G. Fairchild, The Monte-Carlo simulation of the biological effect of the 10B(Nna)7Li reaction in cells and tissue and its implication for boron neutron capture therapy, Radiat. Res. 111: 14 (1987).Google Scholar
  3. 3.
    B. J. Hall, “Radiobiology for the Radiologist,” Harper and Rowe, New York (1986).Google Scholar
  4. 4.
    B. S. Hilaris, ed., “Handbook of Interstitial Brachytherapy”, Publishing Science Group Inc., Criton, MA (1975).Google Scholar
  5. 5.
    H. Hatanaka, ed., “Boron Neutron Capture Therapy for Tumors,” Nishimura Co., Ltd., Japan (1986).Google Scholar
  6. 6.
    R. G. Fairchild and L. J. Goodman, Development and dosimetry of an “epithermal” neutron beam for possible use in neutron capture therapy. II. Absorbed dose measurements in a phantom man, Phys. Med. Biol. 11: 15 (1966).CrossRefGoogle Scholar
  7. 7.
    R. G. Fairchild and V. P. Bood, Current status of neutron capture therapy: Enhancement of tumor dose viabeam filtration and dose rate, and the effects of these parameters on minimum boron content: A theoretical evaluation, Int. J. Radiat. Oncol. Biol. Phys. 11: 831 (1985).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • R. G. Fairchild
    • 1
  1. 1.Medical DepartmentBrookhaven National LaboratoryUptonUSA

Personalised recommendations